Previous Close | 13.08 |
Open | 13.27 |
Bid | 13.14 x 1600 |
Ask | 13.17 x 1100 |
Day's Range | 12.94 - 13.35 |
52 Week Range | 3.06 - 14.03 |
Volume | |
Avg. Volume | 3,227,614 |
Market Cap | 3.051B |
Beta (5Y Monthly) | 0.55 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.02 |
Earnings Date | Aug 07, 2024 - Aug 12, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 13.75 |
Here is how Aclaris Therapeutics (ACRS) and Adma Biologics (ADMA) have performed compared to their sector so far this year.
If you are looking for stocks that are well positioned to maintain their recent uptrend, Adma Biologics (ADMA) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Adma Biologics (ADMA) concluded the recent trading session at $13.58, signifying a -1.31% move from its prior day's close.